Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fascioscapulohumeral Muscular Dystrophy”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Early research (Phase 1)Study completedNCT03123913
What this trial is testing

Study of Testosterone and rHGH in FSHD

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
University of Rochester 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06547216
What this trial is testing

Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
FSHDFSHD1FSHD2+24 more
Avidity Biosciences, Inc. 84
Testing effectiveness (Phase 2)Looking for participantsNCT07435129
What this trial is testing

Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD

Who this might be right for
Facioscapulohumeral Muscular DystrophyFSHD
Scholar Rock, Inc. 60
Not applicableStudy completedNCT02766985
What this trial is testing

Rasch-analysis of Clinical Severity in FSHD

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
University of Kansas Medical Center 44
Not applicableStudy completedNCT06785428
What this trial is testing

Dietary Protein Requirements in Adults With Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Fascioscapulohumeral Muscular Dystrophy
McGill University 10
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Not applicableLooking for participantsNCT04369209
What this trial is testing

A Registered Cohort Study on FSHD1

Who this might be right for
Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1)
Ning Wang, MD., PhD. 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT06907875
What this trial is testing

A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Epicrispr Biotechnologies, Inc. 12
Not applicableStudy completedNCT04694456
What this trial is testing

Pro-inflammatory Cytokines in Facioscapulohumeral Muscular Dystrophy (CYTOKINE-FSH)

Who this might be right for
Muscular Dystrophies
Centre Hospitalier Universitaire de Nice 30
Testing effectiveness (Phase 2)Study completedNCT05747924
What this trial is testing

Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
FSHDFSHD1FSHD2+24 more
Avidity Biosciences, Inc. 90
Testing effectiveness (Phase 2)Ended earlyNCT03943290
What this trial is testing

Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX)

Who this might be right for
Facioscapulohumeral Muscular DystrophyCharcot-Marie-Tooth Disease
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 62
Not applicableLooking for participantsNCT06911190
What this trial is testing

Ten Year Follow-up in FSHD: the FOCUS 3 Study

Who this might be right for
FSHD - Facioscapulohumeral Muscular Dystrophy
Radboud University Medical Center 200
Not applicableLooking for participantsNCT06079567
What this trial is testing

An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression

Who this might be right for
Facioscapulohumeral Muscular Dystrophy Type 2
Centre Hospitalier Universitaire de Nice 50
Not applicableUnknownNCT06517498
What this trial is testing

Disease Burden and Living Situation of Patients With Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Muscular Dystrophy, Facioscapulohumeral
Xi'an Jiaotong University 300
Not applicableStudy completedNCT06363357
What this trial is testing

The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients With Neuromuscular Disorder

Who this might be right for
Muscular Dystrophy, DuchenneOrthotic DevicesUpper Extremity+6 more
Seoul National University Hospital 8
Not applicableUnknownNCT02541292
What this trial is testing

Muscle Inflammation and Fat Infiltration in Patients Affected by FSHD

Who this might be right for
Facioscapulohumeral Muscular Dystrophy 1a
Rigshospitalet, Denmark 10
Not applicableStudy completedNCT07331025
What this trial is testing

Ultrasound Detection of Early Facial Muscle Changes in FSHD: Thickness and Echo Intensity Findings

Who this might be right for
Facioscapulohumeral Muscular DystrophyFacioscapulohumeral Muscular Dystrophy 1Neuromuscular Disease
Koç University 39
Not applicableUnknownNCT06086548
What this trial is testing

Unraveling Metabolic Involvement in Facioscapulohumeral Dystrophy Through Metabolomics

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
University Hospital, Angers 120
Not applicableUnknownNCT06378203
What this trial is testing

Rehabilitation in Muscular Dystrophies From the Hospital Facility to the Home: Pilot Project [RIMUDI]

Who this might be right for
Muscular DystrophiesLimb Girdle Muscular DystrophyFacio-Scapulo-Humeral Dystrophy+1 more
IRCCS Eugenio Medea 10
Testing effectiveness (Phase 2)Study completedNCT02239224
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Participants With Muscular Dystrophy

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
aTyr Pharma, Inc. 20
Next Page